Russia faces shortage of lifesaving drugs as rouble halves in valueBMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h873 (Published 20 February 2015) Cite this as: BMJ 2015;350:h873
- John Follett
Russia’s economic crisis is hurting its health sector, putting severe pressure on spending and pushing up the prices of drugs, prompting cancer specialists to warn of possible shortages.
The rouble has lost about 50% of its value against the US dollar since the start of last year, making foreign made drugs more expensive. Russia imports over 70% of its drugs, and the rouble’s precipitous fall has prompted it to start buying less abroad and to …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial